Species differences in drug glucuronidation: Humanized UDP-glucuronosyltransferase 1 mice and their application for predicting drug glucuronidation and drug-induced toxicity in humans

This publication has 103 references indexed in Scilit:

• Impact of fatty acids on human UDP-glucuronosyltransferase 1A1 activity and its expression in neonatal hyperbilirubinemia
  Scientific Reports, 2013
• Pregnane-x-receptor controls hepatic glucuronidation during pregnancy and neonatal development in humanized UGT1 mice
  Hepatology, 2012
• Reduced Expression of UGT1A1 in Intestines of Humanized UGT1 Mice via Inactivation of NF-κB Leads to Hyperbilirubinemia
  Gastroenterology, 2012
• Pharmacodynamics of dietary phytochemical indoles I3C and DIM: Induction of Nrf2-mediated phase II drug metabolizing and antioxidant genes and synergism with isothiocyanates
  Biopharmaceutics & Drug Disposition, 2011
• A Humanized UGT1 Mouse Model Expressing the UGT1A1*28 Allele for Assessing Drug Clearance by UGT1A1-Dependent Glucuronidation
  Drug Metabolism and Disposition, 2010
• Developmental hyperbilirubinemia and CNS toxicity in mice humanized with theUDP glucuronosyltransferase 1(UGT1) locus
  Proceedings of the National Academy of Sciences, 2010
• Comparison of the Drug-Drug Interactions Potential of Erlotinib and Gefitinib via Inhibition of UDP-Glucuronosyltransferases
  Drug Metabolism and Disposition, 2010
• Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase
  Journal of Biological Chemistry, 2008
• Humanized Mouse Lines and Their Application for Prediction of Human Drug Metabolism and Toxicological Risk Assessment
  The Journal of Pharmacology and Experimental Therapeutics, 2008
• Identification of UDP-glucuronosyltransferase 1A10 in non-malignant and malignant human breast tissues
  Steroids, 2008